Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
about
Nanoscale drug delivery systems and the blood-brain barrierA carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brainPyrroloquinoline quinone inhibits the fibrillation of amyloid proteins.Essential parameters to consider for the characterization of optical imaging probes.A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell modelOxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast.Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems.Imaging tumor burden in the brain with 89Zr-transferrinIn vivo theranostics at the peri-infarct region in cerebral ischemia.NanoART, neuroAIDS and CNS drug delivery.Various drug delivery approaches to the central nervous system.Nanoparticulate systems for drug delivery and targeting to the central nervous system.Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs.Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Designing prodrugs for the treatment of Parkinson's disease.Insights into direct nose to brain delivery: current status and future perspective.The blood-brain barrier: structure, function and therapeutic approaches to cross it.Drug delivery to the ischemic brain.Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.Nanomaterials in controlled drug release.Creation of Novel Cores for β-Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy.Towards a more robust approach to selecting and prosecuting promising targets and compounds.Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications.Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.Nanoparticle accumulation and transcytosis in brain endothelial cell layers.The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein-proofs of crossing blood-brain-barrier
P2860
Q27026978-B6D16806-86D3-44E6-B069-6FC13028B0F2Q27311201-1163AD03-9037-4BE0-91CD-54CE4EC1DB0AQ33772920-D29A13C3-032A-45C1-A94D-34A6BA9FC426Q34356559-40799820-9A34-4364-AB62-D10294AAFA23Q34392217-2BFB0CA6-C056-445C-9206-DE4B93D7C534Q35177868-2D983A1C-2B12-444A-9C81-7582A550DCE0Q35185771-6803B86D-53DC-4862-9870-F7989D077C3CQ36023685-152A7748-91D1-4BB2-9871-AE38D4F80B79Q37106244-21B5F56E-2B8C-4D24-B8EE-1002CCF2E1D4Q37435231-9BDF84FD-8B7A-48A6-B55D-DD432123DEF5Q37538776-5B1865D0-205D-4D35-B176-D4202923391DQ37657525-26CD9105-2B91-4F22-89EE-005B5F3187ECQ37800505-DC41FF80-F352-408A-9CE8-C413DB59FDD9Q37834512-DB0D7FB1-B4A9-43A6-A134-39FE7F1DA486Q37855817-1FD66972-7552-433D-B047-553CCA1E8E81Q37995554-3E253713-A3BB-4009-B60E-C7CF6D7E7884Q38001793-5F8FAF01-A06D-4191-AD94-68DE8A865F10Q38150429-73FFF2C9-185F-4F92-A5F0-C1C818AB3DA6Q38232202-9E373183-0D97-41BC-928D-0BDFD532C16BQ38259305-63A27E53-070F-4803-88B7-2D6550A4E0C8Q39421349-8EF43BAE-97CC-4DBF-91C7-3C1F5F155B88Q39424092-7FC4C39F-3D07-4470-81EF-4174EDEB795FQ39733465-2603DA6D-B36B-4EAE-A902-58AC3F901B26Q39786441-067D2852-6807-4545-AF2F-F9A332DC0F98Q39915228-0DC7526D-3AA7-42CF-8967-AB9247DEB865Q44696669-DC352AFD-F3E7-41B7-9717-41281DFF9EAAQ47720697-70962289-33FD-4F77-B64C-7E0DAFA3CCC7Q47754459-FBFC8CE0-30D8-4D77-896A-3DD09B88CD76Q48968218-EAC0FB01-9C0E-455D-9544-E87DDD3B5B3AQ57777403-FB14AF1A-3D19-46F2-8074-122157966249
P2860
Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances in medicinal c ...... or drug delivery to the brain.
@en
Recent advances in medicinal c ...... or drug delivery to the brain.
@nl
type
label
Recent advances in medicinal c ...... or drug delivery to the brain.
@en
Recent advances in medicinal c ...... or drug delivery to the brain.
@nl
prefLabel
Recent advances in medicinal c ...... or drug delivery to the brain.
@en
Recent advances in medicinal c ...... or drug delivery to the brain.
@nl
P2093
P1476
Recent advances in medicinal c ...... or drug delivery to the brain.
@en
P2093
Adriana Trapani
Angela Lopedota
Giuseppe Trapani
Nunzio Denora
Valentino Laquintana
P304
P356
10.2174/156802609787521571
P577
2009-01-01T00:00:00Z